The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat-induced epitope retrieval

American Journal of Surgical Pathology

Volumn 21, Issue 12, 1997, Pages 1409-1419

  Riera, Jose R ^c   Astengo Osuna, Carlos ^b   Longmate, Jeffrey A ^a   Battifora, Hector ^a,d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c Endocrinology Section   (Spain)

^d City of Hop National Medical Center   (United States)

Author keywords

Epithelial mesothelioma; Heat induced ityepitope retrieval

Indexed keywords

CALRETININ; EPITOPE; MONOCLONAL ANTIBODY; THROMBOMODULIN;

ADENOCARCINOMA; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESOTHELIOMA;

ADENOCARCINOMA; BREAST NEOPLASMS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; EPITOPES; FEMALE; HEAT; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; MESOTHELIOMA; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PLEURAL NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOMODULIN; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 0030696949     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199712000-00003     Document Type: Article

References (51)

1. Ascoli V, Carnovale Scalzo C, Taccogna S, Nardi F. The diagnostic value of thrombomodulin immunolocalization in serious serous effusions. Arch Pathol Lab Med 1995;119:1136-40.
2. Attanoos RL, Goddard H, Gibbs AR. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopatholagy 1996;29:209-15.
3. Attanoos RL, Goddard H, Thomas ND, Jasani B, Gibbs AR. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, BerEP4, Tamm-Horsfall protein and thrombomodulin. Histopathology 1995;27:361-6.
4. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin-and alcohol-fixed tumors. Am J Clin Pathol 1987:88:286-96.
5. Battifora H. Assessment of antigen damage in immunohistochemistry: the vimentin internal control. Am J Pathol 1991;96:669-71.
6. Battifora H, Alsabeh R, Jenkins KA, Gown A. Epitope retrieval (unmasking) in immunohistochemistry. In: Weinstein RS, Graham AR, Anderson RE, et al., eds. Advances in Pathology and Laboratory Medicine. St. Louis, MO: CV Mosby. 1995:101-18.
7. Battifora H, Kopinski M. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer 1985;55:1675-85.
8. Battifora H, McCaughey WTE. Tumors of the Serous Membranes. 3rd ed. Washington, DC: Armed Forces Institute of Pathology, 1995:72.
9. Bignon E, Ogita K, Kishimoto A, Nishizuka Y. Protein kinase C subspecies in estrogen receptor-positive and -negative human breast cancer cell lines. Biochem Biophys Res Commun 1990;171:1071-8.
10. Blobel CA, Moll R, Franke WW, Kayser KW, Gould VE. The intermediate filament cytoskeleton of malignant mesotheliomas and is its diagnostic significance. Am J Pathol 1985;121:235-47.
11. Breiman L, Friedman JH, Olshen R, et al. Classification and Regression Trees. Belmont, CA: Wadworth International Group, 1984.
12. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-54.
13. Chang K, Pai LH, Pass H, et al. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 1992;16:259-61.
14. Churg AM. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 1985;9:360-5.
15. Clark LA, Pregibon D. Tree-based models. In: Chambers JM, Hustie T, eds. Statistical Models in S. Pacific Grove, CA: Wadsworth & Brooks/Cole, 1992.
16. Collins CL, Ordóñez NG, Schaefer R, et al. thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992;141:827-33.
17. Corson JM, Pinkus GS. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen. Am J Pathol 1982;108:80-7.
18. Dejmek A, Hjerpe A. Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis. APMIS 1994;102:255-64.
19. Dejmek A, Hjerpe A. Carcinoembryonic antigen-like reactivity in malignant mesothelioma: a comparison between different commercially available antibodies. Cancer 1994;73:464-9.
20. Delahaye M, Hoogsteden HC, van der Kwast TH. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma. J Pathol 1991;165:137-43.
21. Doglioni C, Dei Tos AP, Laurino L, et al. calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.
22. Frisman DM, McCarthy WF, Schleiff P, Buckner S, Nocito JD, O'Leary TJ. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Mod Pathol 1993;6:179-84.
23. Gaffey MJ, Mills SE, Swanson PE, Zarbo RJ, Shah AR, Wick MR. Immunoreactivity for BER-EP4 in adenocarcinomas. adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 1992;16:593-9.
24. Jasani B, Edwards RE, Thommas ND, Gibbs AR. The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virchows Arch [A] 1985;406:441-8.
25. Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 1988;12:18797.
26. y in the diagnostic discrimination of milignant mesothelioma versus adenocarcinoma. Am J Pathol 1989;135:931-7.
27. Kahn HJ, Thomer PS, Yeger H, Bailey D, Baumal R. Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids, and mesotheliomas using polyclonal and monoclonal anti-keratin antibodies. Am J Clin Pathol 1986;86:556-74.
28. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
29. Lee I, Radosevich JA, Chejfec G, Ma Y, Warren WH, Rosen ST, Gould VE. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Am J Pathol 1986;123:497-507.
30. Lin BT-Y, Colby T, Gown AM, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol 1996;20:1431-9.
31. Marshall RJ, Herbert A, Braye SG, Jones D. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma and reactive mesothelium. J Clin Pathol 1984;37:1215-21.
32. Miettinen M, Kovatich AJ. HBME-1 A monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocancinoma, and soft tissue and bone tumors. Appl Immunohistochem 1995;3:115-22.
33. Moll R, Dhouailly D, Sun T. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14. Virchows Arch [B] 1989;58:129-45.
34. Motoyama T, Watanabe T, Okazaki E, Tanaka N, Watanabe H. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens. Acta Cytol 1995;39:164-70.
35. Mullink H, Henzen-Logmans SC, Alons-van K, JJM, Tadema TM, Meijer CJLM. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma. Virchows Arch [A] 1986;52:55-65.
36. a and anti-Tn antibodies. Hum Pathol 1989;20:53-7.
37. O'Hara CJ, Corson JM, Pinkus GS, Stand RA. ME1 : a monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and entrapulmonary malignancies. Am J Pathol 1990;136:421-8.
38. Oidóñez NG. The immunohistochemical diagnosis of mesotheloma. Am J Surg 1989;13:276-91.
39. Otis CN, Carter D, Cole S, Battifora H. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Am J Surg Pathol 1987;11:445-56.
40. Sheibani K, Battifora H, Burke JS. Antigenic phenotype of malig- nant mesotheliomas and pulmonary adecarcinomas. An immuno- histologic analysis demonstrating the value of LeuM1 antigen. Am J Pathol 1986;123:212-9.
41. Sheibani K, Battifora H, Burke JS, Rappaport H. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Srug 1986;10:227-36.
42. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 1992;23:107-16.
43. Sheibani K, Shin SS, Kezirian J, Weiss LM. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma vs. adenocarcinoma. Am J Surg Pathol 1991;15:779-84.
44. Singh G, Singh J. Ordóñez NG, et al. Expression of a 130-kDa mesothelial and ciliated cell Ag (MCp130) in normal and developing human and rat lung and its role as a for diagnostic marker for mesotheliomas and tumors of the female reproductive system. Lab Invest 1995;73:48-58.
45. Stahel RA, O'Hara CJ, Waibel R, Martin A. Monoclonal antibod- ies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma. Int J Cancer 1988;41:21823
46. Strickler JG, Herndier BG, Rouse RV. Immunohistocheinical staining in malignant mesotheliomas. Am J Clin Pathol 1987;88:610-4.
47. Vortmeyer AO, Preuss J, Padberg B-C, Kastendieck H, Sehröder S. Immunocytochemical differential diagnosis of diffuse malignant pleural mesotheliomas - a clinicomorphological study of 158 cases. Anticancer Res 1991;11:889-94.
48. Walts AE, Said JW, Shintaku PI, Sassoon AF, Bank-Sclegel SP. Keratins of different molecular weight in exfoliated mesothelial and adenocarcinoma cells - an aid to cell identification. Am J Clin Pathol 1984;81:42-6.
49. Weiss LM, Battifora H. The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. Hum 1993;24:345-6.
50. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohisto- logic study of 103 cases. Hum Pathol 1990;21:759-66.
51. Wu Y, Parker LM, Binder NE, et al. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 1982;31:693-703.